Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUREKA: Rosuvastatin in Acute Ischemic Stroke
NCT01364220Phase 3Terminated
- Sponsor
- Severance Hospital
- Start
- Aug 2010
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in ischemic stroke, sponsored by Severance Hospital. Started Aug 2010; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01364220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01364220.